Targeting hedgehog in hematologic malignancy

Blood

Volumn 119, Issue 10, 2012, Pages 2196-2204

  Irvine, David A ^a   Copland, Mhairi ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; CASEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOPAMINE; CYCLOPHOSPHAMIDE; DASATINIB; DEXAMETHASONE; ERISMODEGIB; IMATINIB; KRUPPEL LIKE FACTOR 6; LENALIDOMIDE; LEQ506; NILOTINIB; UNCLASSIFIED DRUG; VISMODEGIB;

ACUTE LYMPHOCYTIC LEUKEMIA; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; GLIOMA; HEDGEHOG; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HUMAN; MEDULLOBLASTOMA; MULTIPLE MYELOMA; MYELOFIBROSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHABDOMYOSARCOMA; UBIQUITINATION;

EID: 84858009739     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-10-383752     Document Type: Review

References (100)

1. Nüsslein-Volhard C, Wieschaus E. Mutations affecting segment number and polarity in Drosophila. Nature. 1980;287(5785):795-801. (Pubitemid 11214475)
2. Chiang C, Litingtung Y, Lee E, et al. Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature. 1996; 383(6599):407-413. (Pubitemid 26330823)
3. Roessler E, Belloni E, Gaudenz K, et al. Mutations in the human Sonic Hedgehog gene cause holoprosencephaly. Nat Genet. 1996;14(3):357-360.
4. Blank U, Karlsson G, Karlsson S. Signaling pathways governing stem-cell fate. Blood. 2008; 111(2):492-503.
5. Cridland SO, Keys JR, Papathanasiou P, Perkins AC. Indian hedgehog supports definitive erythropoiesis. Blood Cells Mol Dis. 2009;43(2): 149-155.
6. Dyer MA, Farrington SM, Mohn D, Munday JR, Baron MH. Indian hedgehog activates hematopoiesis and vasculogenesis and can respecify prospective neurectodermal cell fate in the mouse embryo. Development. 2001;128(10): 1717-1730. (Pubitemid 32514853)
7. Ingham PW, Placzek M. Orchestrating ontogenesis: variations on a theme by sonic hedgehog. Nat Rev Genet. 2006;7(11):841-850. (Pubitemid 44607100)
8. Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature. 2004;432(7015):324-331. (Pubitemid 39551660)
9. Trowbridge JJ, Scott MP, Bhatia M. Hedgehog modulates cell cycle regulators in stem cells to control hematopoietic regeneration. Proc Natl Acad Sci U S A. 2006;103(38):14134-14139. (Pubitemid 44452992)
10. Ruiz i Altaba A, Mas C, Stecca B. The Gli code: an information nexus regulating cell fate, stemness and cancer. Trends Cell Biol. 2007;17(9): 438-447. (Pubitemid 47505310)
11. Reifenberger J, Wolter M, Knobbe CB, et al. Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. Br J Dermatol. 2005;152(1):43-51.
12. Dierks C, Grbic J, Zirlik K, Beigi R, Englund NP, Guo GR. Essential role of stromally induced hedgehog signaling in B-cell malignancies. Nat Med. 2007;13(8):944-951. (Pubitemid 47222041)
13. Dierks C, Beigi R, Guo GR, Zirlik K, Stegert MR, Manley P. Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation. Cancer Cell. 2008;14(3):238-249.
14. Jiang J, Hui CC. Hedgehog signaling in development and cancer. Dev Cell. 2008;15(6):801-812.
15. Liu S, Dontu G, Mantle ID, et al. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res. 2006;66(12):6063-6071.
16. O'Brien CA, Kreso A, Jamieson CHM. Cancer stem cells and self-renewal. Clin Cancer Res. 2010;16(12):3113-3120.
17. Zhao C, Chen A, Jamieson CH, et al. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature. 2009; 458(7239):776-779.
18. Peacock CD, Wang Q, Gesell GS, Corcoran-Schwartz IM, Jones E, Kim J. Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc Natl Acad Sci U S A. 2007;104(10):4048-4053. (Pubitemid 47181576)
19. Lee JJ, Ekker SC, von Kessler DP, Porter JA, Sun BI, Beachy PA. Autoproteolysis in hedgehog protein biogenesis. Science. 1994;266(5190): 1528-1537.
20. Beachy PA, Cooper MK, Young KE, et al. Multiple roles of cholesterol in hedgehog protein biogenesis and signaling. Cold Spring Harb Symp Quant Biol. 1997;62:191-204. (Pubitemid 28198537)
21. Pathi S, Pagan-Westphal S, Baker DP, et al. Comparative biological responses to human Sonic, Indian, and Desert hedgehog. Mech Dev. 2001;106(1):107-117. (Pubitemid 32701078)
22. Bitgood MJ, Shen L, McMahon AP. Sertoli cell signaling by Desert hedgehog regulates the male germline. Curr Biol. 1996;6(3):298-304.
23. Robbins DJ, Hebrok M. Hedgehogs: la dolce vita. Workshop on Hedgehog-Gli Signaling in Cancer and Stem Cells. EMBO Rep. 2007;8(5):451-455.
24. Ioannou YA. The structure and function of the Niemann-Pick C1 protein. Mol Genet Metab. 2000;71(1):175-181.
25. Ayers KL, Therond PP. Evaluating Smoothened as a G-protein-coupled receptor for Hedgehog signalling. Trends Cell Biol. 2010;20(5):287-298.
26. Bijlsma MF, Spek CA, Zivkovic D, van deWater S, Rezaee F, Peppelenbosch MP. Repression of smoothened by patched-dependent (Pro-)vitamin D3 secretion. Plos Biol. 2006;4(8):e232.
27. Corcoran RB, Scott MP. Oxysterols stimulate Sonic hedgehog signal transduction and proliferation of medulloblastoma cells. Proc Natl Acad Sci U S A. 2006;103(22):8408-8413. (Pubitemid 43838468)
28. Denef N, Neubüser D, Perez L, Cohen SM. Hedgehog induces opposite changes in turnover and subcellular localization of patched and smoothened. Cell. 2000;102(4):521-531.
29. Sasaki H, Nishizaki Y, Hui C, Nakafuku M, Kondoh H. Regulation of Gli2 and Gli3 activities by an amino-terminal repression domain: implication of Gli2 and Gli3 as primary mediators of Shh signaling. Development. 1999;126(17):3915-3924. (Pubitemid 29440488)
30. Hui CC, Angers S. Gli proteins in development and disease. Annu Rev Cell Dev Biol. 2011;27: 513-537.
31. Corbit KC. Vertebrate smoothened functions at the primary cilium. Nature. 2005;437(7061):1018-1021. (Pubitemid 41486982)
32. Rohatgi R, Milenkovic L, Scott MP. Patched 1 regulates hedgehog signaling at the primary cilium. Science. 2007;317(5836):372-376. (Pubitemid 47106377)
33. Kim J, Kato M, Beachy PA. Gli2 trafficking links Hedgehog-dependent activation of Smoothened in the primary cilium to transcriptional activation in the nucleus. Proc Natl Acad Sci U S A. 2009; 106(51):21666-21671.
34. Finetti F, Paccani SR, Riparbelli MG, et al. Intraflagellar transport is required for polarized recycling of the TCR/CD3 complex to the immune synapse. Nat Cell Biol. 2009;11(11):1332-1339.
35. Humke EW, Dorn KV, Milenkovic L, Scott MP, Rohatgi R. The output of Hedgehog signaling is controlled by the dynamic association betweenSuppressor of Fused and the Gli proteins. Genes Dev. 2010;24(7):670-682.
36. Kise Y, Morinaka A, Teglund S, Miki H. Sufu recruits GSK3beta for efficient processing of Gli3. Biochem Biophys Res Commun. 2009;387(3): 569-574.
37. Tempé D, Casas M, Karaz S, Blanchet-Tournier MF, Concordet JP. Multisite protein kinase A and glycogen synthase kinase 3beta phosphorylation leads to Gli3 ubiquitination by SCFbetaTrCP. Mol Cell Biol. 2006;26(11):4316- 4326. (Pubitemid 43788030)
38. Pan Y, Wang C, Wang B. Phosphorylation of Gli2 by protein kinase A is required for Gli2 processing and degradation and the Sonic Hedgehogregulated mouse development. Dev Biol. 2009; 326(1):177-189.
39. St-Jacques B, Hammerschmidt M, McMahon AP. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev. 1999;13(16): 2072-2086. (Pubitemid 29407348)
40. Cumano A, Godin I. Ontogeny of the hematopoietic system. Annu Rev Immunol. 2007;25:745-785. (Pubitemid 46697923)
41. Gering M, Patient R. Hedgehog signaling is required for adult blood stem cell formation in zebrafish embryos. Dev Cell. 2005;8(3):389-400. (Pubitemid 40309809)
42. Peeters M, Ottersbach K, Bollerot K, Orelio C, de Bruijn M, Wijgerde M. Ventral embryonic tissues and Hedgehog proteins induce early AGM hematopoietic stem cell development. Development. 2009;136(15):2613-2621.
43. Bhardwaj G, Murdoch B, Wu D, Baker DP, Williams KP, Chadwick K. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat Immunol. 2001;2(2):172-180. (Pubitemid 33707938)
44. Kobune M, Ito Y, Kawano Y. Indian hedgehog gene transfer augments hematopoietic support of human stromal cells including NOD/SCID-[beta]2m-/- repopulating cells. Blood. 2004; 104(4):1002-1009. (Pubitemid 39038019)
45. Siggins SL, Nguyen N-YN, McCormack MP, et al. The Hedgehog receptor Patched1 regulates myeloid and lymphoid progenitors by distinct cellextrinsic mechanisms. Blood. 2009;114(5):995-1004.
46. Gao J, Graves S, Koch U, et al. Hedgehog signaling is dispensable for adult hematopoietic stem cell function. Cell Stem Cell. 2009;4(6):548-558.
47. Hofmann I, Stover EH, Cullen DE, Mao J, Morgan KJ, Lee BH. Hedgehog signaling is dispensable for adult murine hematopoietic stem cell function and hematopoiesis. Cell Stem Cell. 2009;4(6):559-567.
48. Merchant A, Joseph G, Wang Q, Brennan S, Matsui W. Gli1 regulates the proliferation and differentiation of HSCs and myeloid progenitors. Blood. 2010;115(12):2391-2396.
49. Outram SV, Hager-Theodorides AL, Shah DK, et al. Indian hedgehog (Ihh) both promotes and restricts thymocyte differentiation. Blood. 2009; 113(10):2217-2228.
50. El Andaloussi AE, Graves S, Meng F, Mandal M, Mashayekhi M, Aifantis I. Hedgehog signaling controls thymocyte progenitor homeostasis and differentiation in the thymus. Nat Immunol. 2006; 7(4):418-426.
51. Outram SV, Varas A, Pepicelli CV, Crompton T. Hedgehog signaling regulates differentiation from double-negative to double-positive thymocyte. Immunity. 2000;13(2):187-197.
52. Shah DK, Hager-Theodorides AL, Outram SV, Ross SE, Varas A, Crompton T. Reduced thymocyte development in sonic hedgehog knockout embryos. J Immunol. 2004;172(4):2296-2306. (Pubitemid 38182377)
53. Uhmann A, Dittmann K, Nitzki F, et al. The Hedgehog receptor Patched controls lymphoid lineage commitment. Blood. 2007;110(6):1814-1823. (Pubitemid 47443892)
54. Uhmann A, van den Brandt J, Dittmann K, et al. T-cell development critically depends on prethymic stromal patched expression. J Immunol. 2011;186(6):3383-3391.
55. Von Hoff DD, LoRusso PM, Rudin CM, Reddy JC, Yauch RL, Tibes R. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med. 2009;361(12):1164-1172.
56. Teglund S, Toftgard R. Hedgehog beyond medulloblastoma and basal cell carcinoma. Biochim Biophys Acta. 2010;1805(2):181-208.
57. Gorlin RJ. Nevoid basal cell carcinoma (Gorlin) syndrome. Genet Med. 2004;6(6):530-539. (Pubitemid 39576548)
58. Grachtchouk M. Basal cell carcinomas in mice overexpressing Gli2 in skin. Nat Genet. 2000; 24(3):216-217. (Pubitemid 30132187)
59. Katoh Y, Katoh M. Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation. Curr Mol Med. 2009;9(7):873-886.
60. .Wolter M, Reifenberger J, Sommer C, Ruzicka T, Reifenberger G. Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res. 1997;57(13):2581-2585. (Pubitemid 27283761)
61. Ehtesham M, Sarangi A, Valadez JG, et al. Ligand-dependent activation of the hedgehog pathway in glioma progenitor cells. Oncogene. 2007;26(39):5752- 5761. (Pubitemid 47312811)
62. Ruiz i Altaba A. Therapeutic inhibition of Hedgehog-GLI signaling in cancer: epithelial, stromal, or stem cell targets? Cancer Cell. 2008; 14(4):281-283.
63. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414(6859):105-111. (Pubitemid 33041634)
64. Holyoake T, Jiang X, Eaves C, Eaves A. Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. Blood. 1999;94(6):2056-2064. (Pubitemid 29430422)
65. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3(7):730-737. (Pubitemid 27298715)
66. Jones RJ, Gocke CD, Kasamon YL, et al. Circulating clonotypic B cells in classic Hodgkin lymphoma. Blood. 2009;113(23):5920-5926.
67. Brennan SK, Meade B, Wang Q, Merchant AA, Kowalski J, Matsui W. Mantle cell lymphoma activation enhances bortezomib sensitivity. Blood. 2010;116(20):4185-4191.
68. Chen JK, Taipale J, Cooper MK, Beachy PA. Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev. 2002; 16(21):2743-2748. (Pubitemid 35253140)
69. LoRusso PM. Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally-advanced or metastatic solid tumors. Clin Cancer Res. 2011;17(8):2502-2511.
70. Irvine DA, Heaney NB, Holyoake TL. Optimising chronic myeloid leukaemia therapy in the face of resistance to tyrosine kinase inhibitors: a synthesis of clinical and laboratory data. Blood Rev. 2010;24(1):1-9.
71. Mahon FX, Rea D, Guilhot J, Guilhot F, Huguet F, Nicolini F. Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial. Lancet Oncol. 2010;11(11): 1029-1035.
72. Ross DM, Branford S, Seymour JF, et al. Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCR. Leukemia. 2010;24(10):1719-1724.
73. Corbin AS, Agarwal A, Loriaux M, Cortes J, Deininger MW, Druker BJ. Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity. J Clin Invest. 2011;121(1):396-409.
74. Jamieson CH, Ailles LE, Dylla SJ, et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med. 2004;351(7):657-667. (Pubitemid 39063268)
75. Radich JP, Dai H, Mao M, Oehler V, Schelter J, Druker B. Gene expression changes associated with progression and response in chronic myeloid leukemia. Proc Natl Acad Sci U S A. 2006;103(8): 2794-2799.
76. Irvine DA, Zhang B, Ho Y, et al. Combination of the hedgehog pathway inhibitor LDE225 and nilotinib targets the leukemic stem cell population in chronic myeloid leukemia. Haematologica. 2011; 96(suppl 2):221. Abstract 521.
77. Schairer A, Shih A, Geron I, et al. Human blast crisis leukemia stem cell inhibition with a novel smoothened antagonist. ASH Annual Meeting Abstracts. 2010;116(21):1223a.
78. Huff CA, Matsui W. Multiple myeloma cancer stem cells. J Clin Oncol. 2008;26(17):2895-2900.
79. Matsui W, Huff CA, Wang Q, Malehorn MT, Barber J, Tanhehco Y. Characterization of clonogenic multiple myeloma cells. Blood. 2004; 103(6):2332-2336. (Pubitemid 38326254)
80. Matsui W, Wang Q, Barber JP, et al. Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance. Cancer Res. 2008; 68(1):190-197. (Pubitemid 351380120)
81. le Viseur C, Hotfilder M, Bomken S, et al. In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties. Cancer Cell. 2008; 14(1):47-58. (Pubitemid 351885495)
82. Goardon N, Marchi E, Atzberger A, et al. Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia. Cancer Cell. 2011;19(1):138-152.
83. de Jonge-Peeters SDPWM, Kuipers F, de Vries EGE, Vellenga E. ABC transporter expression in hematopoietic stem cells and the role in AML drug resistance. Crit Rev Oncol Hematol. 2007;62(3): 214-226.
84. Steffen B, Knop M, Bergholz U, et al. AML1/ETO induces self-renewal in hematopoietic progenitor cells via the Groucho-related amino-terminal AES protein. Blood. 2011;117(16):4328-4337.
85. Huntly BJP, Shigematsu H, Deguchi K, et al. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell. 2004;6(6): 587-596. (Pubitemid 40017702)
86. Hofmann I, Stover EH, Cullen DE, et al. Hedgehog signaling is dispensable for adult murine hematopoietic stem cell function and hematopoiesis. Cell Stem Cell. 2009;4(6):559-567.
87. Hegde S, Hankey P, Paulson RF. Self renewal of leukemia stem cells in friend virus induced erythroleukemia requires proviral insertional activation of Spi1 and hedgehog signaling, but not mutation of p53. Stem Cells. 2012;30(2):121-130.
88. Queiroz KC, Ruela-de-Sousa RR, Fuhler GM, et al. Hedgehog signaling maintains chemoresistance in myeloid leukemic cells. Oncogene. 2010; 29(48):6314-6322.
89. Ji Z, Mei FC, Johnson BH, Thompson EB, Cheng X. Protein kinase A, not Epac, suppresses hedgehog activity and regulates glucocorticoid sensitivity in acute lymphoblastic leukemia cells. J Biol Chem. 2007;282(52):37370-37377.
90. Bai LY, Chiu CF, Lin CW, et al. Differential expression of Sonic hedgehog and Gli1 in hematological malignancies. Leukemia. 2007;22(1):226-228.
91. Lin TL, Wang QH, Brown P, Peacock C, Merchant AA, Brennan S. Self-renewal of acute lymphocytic leukemia cells is limited by the hedgehog pathway inhibitors cyclopamine and IPI-926. Plos One. 2010;5:e15262.
92. Kobune M, Takimoto R, Murase K, et al. Drug resistance is dramatically restored by hedgehog inhibitors in CD34+ leukemic cells. Cancer Sci. 2009;100(5):948-955.
93. Kim JE, Singh RR, Cho-Vega JH, et al. Sonic hedgehog signaling proteins and ATP-binding cassette G2 are aberrantly expressed in diffuse large B-cell lymphoma. Mod Pathol. 2009;22(10): 1312-1320.
94. Singh RR, Kim JE, Davuluri Y, Drakos E, Cho-Vega JH, Amin HM. Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation. Leukemia. 2010;24(5):1025-1036.
95. Hegde GV, Munger CM, Emanuel K, et al. Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma. Mol Cancer Ther. 2008;7(6):1450-1460.
96. Hegde GV, Peterson KJ, Emanuel K, et al. Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target. Mol Cancer Res. 2008;6(12):1928-1936.
97. Desch P, Asslaber D, Kern D, et al. Inhibition of GLI, but not Smoothened, induces apoptosis in chronic lymphocytic leukemia cells. Oncogene. 2010;29(35):4885-4895.
98. Decker S, Zirlik K, Djebatchie L, et al. Trisomy 12 and elevated GLI1 and PTCH1 transcript levels are biomarkers for Hedgehog-inhibitor responsiveness in CLL [published online ahead of print November 30, 2011]. Blood. 2012. doi: 10.1182/blood-2011-06-359075.
99. Singh RR, Cho-Vega JH, Davuluri Y, et al. Sonic hedgehog signaling pathway is activated in ALK-positive anaplastic large cell lymphoma. Cancer Res. 2009;69(6):2550-2558.
100. Greaves WO, Kim JE, Singh RR, et al. Glioma-associated oncogene homologue 3, a hedgehog transcription factor, is highly expressed in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma. Hum Pathol. 2011;42(11):1643-1652.